Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Crispr Therapeutics Ag (NQ: CRSP ) 48.92 +0.63 (+1.30%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Crispr Therapeutics Ag < Previous 1 2 3 4 5 6 7 8 9 ... 29 30 Next > 3 Bargain Stocks to Buy in a Market That's Priced for Perfection Today 7:30 EDT Yes, bargains can still be found in the stock market. Via The Motley Fool Why I Keep Buying These 14 Incredible Growth Stocks October 16, 2024 This diverse set of growth stocks offers tremendous opportunities in the fields of AI, space, biotech, and emerging industries. Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence Is CRISPR Therapeutics Stock a Buy? October 13, 2024 The markets this biotech is looking to enter could be extremely lucrative. Via The Motley Fool 2 Biotech Stocks That Are Screaming Buys This Month October 12, 2024 They won't remain southbound forever. Via The Motley Fool This Healthcare Growth Stock Could Be a Steal of a Deal Right Now October 05, 2024 CRISPR Therapeutics is trading around multiyear lows. Via The Motley Fool These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer October 02, 2024 Market-beating returns could be on the way for patient investors in these two up-and-coming healthcare growth stocks. Via The Motley Fool Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. September 26, 2024 Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths. Via Investor's Business Daily 3 Dirt Cheap Stocks to Buy Right Now September 21, 2024 Bargain hunters should love these great stocks. Via The Motley Fool Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy? September 19, 2024 There's a lot of growth on the way, and soon. Via The Motley Fool 1 Biotech Stock Down 62% to Buy and Hold September 12, 2024 It's an excellent opportunity to buy shares of what could become a biotech giant on the dip. Via The Motley Fool 3 No-Brainer Biotech Stocks to Buy With $200 Right Now September 12, 2024 An investment in these players today could score a big win down the road. Via The Motley Fool Looking for Stock Bargains With Room to Run? Try This. September 11, 2024 Investing tips from Bill Mann, The Motley Fool's director of small-cap research. Via The Motley Fool Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal? September 05, 2024 Is the potential upside for CRISPR Therapeutics too massive to ignore? Via The Motley Fool 3 Monster Biotech Stocks to Buy Before 2025 September 02, 2024 These companies are nearly in the sweet spot of risk versus reward in biotech. Via The Motley Fool Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 August 26, 2024 The companies are chasing major innovations. Via The Motley Fool Got the Market Sell-Off Blues? Do These 3 Things Right Now August 11, 2024 You aren't powerless in the face of what the market throws at you. Via The Motley Fool Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom August 08, 2024 The "Mad Money" host says Dexcom had "a real bad miss... they still really haven't fully explained why that is." Via Benzinga 7 Biotech Stocks to Buy for Their Game-Changing Potential August 08, 2024 Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks. Via InvestorPlace The 3 Best Gene Editing Stocks to Buy in August 2024 August 07, 2024 These are the best gene-editing stocks to buy as the biotechs pursue precision therapies to cure rare diseases. Via InvestorPlace Is It Too Late to Buy Vertex Pharmaceuticals Stock? August 06, 2024 Shares of the rare disease drugmaker are already up more than 40% over the past year. Via The Motley Fool CRSP Stock Earnings: CRISPR Therapeutics Beats EPS, Misses Revenue for Q2 2024 August 05, 2024 CRSP stock results show that CRISPR Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace Prediction: These Could Be the Best-Performing Growth Stocks Through 2030 August 05, 2024 Great companies are found in every type of market landscape. Via The Motley Fool Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker August 04, 2024 The biotech recently became a commercial-stage company. Via The Motley Fool 3 Unstoppable Stocks to Buy in August August 03, 2024 It's not hard to envision how all three of these stocks can deliver exceptional growth. Via The Motley Fool 10 Best Small and Mid-Cap Stocks to Consider Buying in August August 01, 2024 A shift in market dynamics could favor these 10 growth stocks. Via The Motley Fool Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought July 31, 2024 The strugglingh stock investor did a little bit of shopping on Tuesday, adding to some of her existing positions. Via The Motley Fool The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024 July 29, 2024 The investing guru likes to take the pulse of where the world will be tomorrow and these Cathie Wood stocks reflect that vision. Via InvestorPlace 3 Small-Cap Stocks to Buy at a 52-Week Low July 27, 2024 The Russell 2000 is hinting at sector rotation, meaning it’s time for bargain hunters to look for small-cap stocks at 52-week lows Via InvestorPlace 3 Gene Editing Stocks Shaping the Future of Medicine July 22, 2024 Gene editing stocks offer a bold venture into biopharma's future, leveraging CRISPR technology for transformative healthcare solutions Via InvestorPlace 3 Monster Stocks in the Making to Buy Right Now July 20, 2024 They're small now, but these stocks could grow much larger. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 29 30 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.